Cargando…

HBV Infection Status Does Not Influence the Initial Metastatic Pattern and the Prognosis of Breast Cancer Patients with de novo and Relapsed Metastatic Disease

PURPOSE: This study aimed to evaluate the influence of hepatitis B virus (HBV) infection status on the initial metastatic pattern and prognosis in metastatic breast cancer (MBC). METHODS: MBC patients admitted to Chongqing University Cancer Hospital between January 2011 and December 2019 were enroll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ningning, Tao, Dan, Lei, Haike, Shao, Qing, Liu, Yumin, Long, Hua, Zeng, Xiaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038213/ https://www.ncbi.nlm.nih.gov/pubmed/35479830 http://dx.doi.org/10.2147/JIR.S355301

Ejemplares similares

Different risk and prognostic factors for liver metastasis of breast cancer patients with de novo and relapsed distant metastasis in a Chinese population
por: Zhang, Ningning, et al.
Publicado: (2023)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer
por: Wei, Xiao-li, et al.
Publicado: (2013)

De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis
por: Zhang, Li, et al.
Publicado: (2020)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

MBCL-04. 5 – AZACYTIDINE IN TREATMENT OF CHILDREN WITH DE NOVO AND RELAPSED METASTATIC MEDULLOBLASTOMA: RESULTS OF INTERCENTER PILOT STUDY
por: Levashov, Andrey, et al.
Publicado: (2020)

Conditional Survival in de novo Metastatic Urothelial Carcinoma
por: Pal, Sumanta Kumar, et al.
Publicado: (2015)

Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database
por: Lauritsen, Jakob, et al.
Publicado: (2023)

Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer
por: Shiota, Masaki, et al.
Publicado: (2021)

A Retrospective Clinicopathological Study of Osteosarcoma Patients with Metachronous Metastatic Relapse
por: Bao, Junjie, et al.
Publicado: (2019)

Real-world evidence of the management and prognosis of young women (⩽40 years) with de novo metastatic breast cancer
por: Mallet, Amélie, et al.
Publicado: (2022)

Shoulder Mass as the Initial Presentation of Metastatic Hepatocellular Carcinoma
por: Laskar, Derek B., et al.
Publicado: (2017)

Leptomeningeal metastasis from de novo metastatic nasopharyngeal carcinoma: a case report
por: Zhang, Xin, et al.
Publicado: (2022)

Breast Cancer Metastatic Dormancy and Relapse: An Enigma of Microenvironment(s)
por: Elkholi, Islam E., et al.
Publicado: (2022)

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
por: Barcenas, Carlos H., et al.
Publicado: (2021)

Clubfoot relapse: does presentation differ based on age at initial relapse?
por: Mahan, S. T., et al.
Publicado: (2017)

A nonendemic analysis of the patterns and prognosis of de novo metastatic nasopharyngeal carcinomas in older patients aged ≥ 65 years
por: Liu, Baoqiu, et al.
Publicado: (2022)

The AURORA initiative for metastatic breast cancer
por: Zardavas, D, et al.
Publicado: (2014)

Metastatic-initiating cells and lipid metabolism
por: Benitah, Salvador Aznar
Publicado: (2017)

Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor
por: Chen, Meiting, et al.
Publicado: (2021)

Locally relapsed and metastatic uterine leiomyoma: A case report
por: Londero, Ambrogio P, et al.
Publicado: (2008)

Breast relapse after metastatic alveolar rhabdomyosarcoma: Is it an incurable entity?
por: Iniesta, Silvia López, et al.
Publicado: (2016)

Ureteropelvic Junction Obstruction Secondary to Metastatic Relapse of Breast Cancer
por: Shah, Paras H., et al.
Publicado: (2015)

Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients
por: Dürr, Hans Roland, et al.
Publicado: (2018)

Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2020)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

Prognostic value of PTEN in de novo diagnosed metastatic prostate cancer
por: Zhang, Jun-Yu, et al.
Publicado: (2021)

Changes in survival in de novo metastatic cancer in an era of new medicines
por: Luyendijk, Marianne, et al.
Publicado: (2023)

An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer
por: Cheng, Shao-Xian, et al.
Publicado: (2023)

Development of an immune-related gene pairs index for the prognosis analysis of metastatic melanoma
por: Huang, Rong-zhi, et al.
Publicado: (2021)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Characteristics of recurrence, predictors for relapse and prognosis of rapid relapse triple-negative breast cancer
por: Cai, Shuang-Long, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio is a negative prognostic biomarker for luminal A breast cancer
por: Xiang, Yimei, et al.
Publicado: (2023)

Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer
por: Chen, Jun-Ru, et al.
Publicado: (2019)

Smoking cessation before initiation of chemotherapy in metastatic non-small cell lung cancer: influence on prognosis
por: Linhas, Ana Rita Diegues, et al.
Publicado: (2018)

Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study
por: Zeng, Fujuan, et al.
Publicado: (2021)

Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status
por: Chen, Wen-Chieh, et al.
Publicado: (2022)

Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1
por: Li, Yung-Tsung, et al.
Publicado: (2021)

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer
por: Morgan, Robert D, et al.
Publicado: (2019)

Metastatic-directed therapy using PSMA-PET/CT at PSA relapse
por: Lilleby, Oscar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qq8nchf2f01gkk5hq8rf4v3an2